• Home  / 
  • On the Move
  •  /  Valeant Pharmaceuticals Appoints Arthur Shannon As Senior Vice President, Head Of Investor Relations And Communications

Valeant Pharmaceuticals Appoints Arthur Shannon As Senior Vice President, Head Of Investor Relations And Communications


On The MoveValeant Pharmaceuticals International has appointed Arthur J. Shannon to the role of  Senior Vice President, Head of Investor Relations and Communications.

Prior to the appointment Arthur was Vice President of Global Corporate Affairs and European Investor Relations for 11 years at Perrigo. Prior to that, he served as vice president of Investor Relations for the Energy/Utility division at Thomson Financial, and earlier in his career, he was a senior director of Investor Relations at Dynegy, Inc.


Help Me Find

Login Here